Compare DexCom, Inc. (DXCM) vs Seagate Technology Holdings PLC (STX) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

STX trades at $753.18, down 14.25% in the past 24 hours amid broader market volatility. The stock exhibits strong fundamentals with a 21.6% net income margin and consistent earnings beats, but valuation ratios like a P/E of 78.59 and P/B of 171.15 suggest premium pricing. Technical indicators are bearish, with support near $743, while analyst sentiment remains positive with a $987.86 consensus price target. Recent news highlights AI-driven storage demand and a Wells Fargo upgrade on July 10, 2026.

Outlook: STX benefits from robust AI infrastructure demand and margin expansion, but high debt levels and intense competition pose risks. The stock offers upside if earnings growth persists, yet investors should monitor debt sustainability and competitive pressures. Near-term volatility is likely around the Q2 2026 earnings report on July 28, 2026.